Use of Remdesivir in Myasthenia gravis and COVID ‐19

We describe the first reported clinical course of three patients with myasthenia gravis who safely received remdesivir in combination with dexamethasone for the management of COVID-19.

Source: Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy - April 27, 2021 Category: Drugs & Pharmacology Authors: Bradley J. Peters, Alejandro A. Rabinstein, Hilary M. DuBrock Tags: CASE REPORT Source Type: research